Advantages of Tyrosine Kinase Anti-Angiogenic Cediranib over Bevacizumab: Cell Cycle Abrogation and Synergy with Chemotherapy

Angiogenesis plays a crucial role in tumor development and metastasis. Both bevacizumab and cediranib have demonstrated activity as single anti-angiogenic agents in endometrial cancer, though subsequent studies of bevacizumab combined with chemotherapy failed to improve outcomes compared to chemothe...

Volledige beschrijving

Bibliografische gegevens

Hoofdauteurs:	Jianling Bi, Garima Dixit, Yuping Zhang, Eric J. Devor, Haley A. Losh, Andreea M. Newtson, Kristen L. Coleman, Donna A. Santillan, Thorsten Maretzky, Kristina W. Thiel, Kimberly K. Leslie
Formaat:	Artigo
Taal:	Inglês
Gepubliceerd in:	MDPI AG 2021-07-01
Reeks:	Pharmaceuticals
Onderwerpen:	endometrial cancer bevacizumab cediranib patient-derived organoid models 3D culture personalized medicine
Online toegang:	https://www.mdpi.com/1424-8247/14/7/682
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!